Spots Global Cancer Trial Database for adult patients
Every month we try and update this database with for adult patients cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Treatment of Adult ALL With an MRD-directed Programme. | NCT00358072 | Acute Lymphobla... | Postremission c... | 15 Years - 65 Years | Northern Italy Leukemia Group | |
| Study of Chemotherapy in Combination With All-trans Retinoic Acid (ATRA) With or Without Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia (AML) and Mutant Nucleophosmin-1 (NPM1) Gene Mutation | NCT00893399 | Acute Myeloid L... | Gemtuzumab Ozog... standard chemot... | 18 Years - | University of Ulm | |
| Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2 | NCT04628026 | Acute Myeloid L... Myelodysplastic... | Venetoclax Placebo Standard chemot... Autologous stem... Allogeneic stem... | 18 Years - | University of Ulm | |
| TAS-117 in Patients With Advanced Solid Tumors Harboring Germline PTEN Mutations | NCT04770246 | Advanced or Met... Advanced or Met... | TAS-117 TAS-117 TAS-117 TAS-117 | 12 Years - | Taiho Oncology, Inc. | |
| Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin Lymphoma | NCT01290120 | Burkitt Lymphom... B-ALL | Chemotherapy-Ri... | 15 Years - | Northern Italy Leukemia Group | |
| Stereotactic Directional Vacuum-Assisted Breast Biopsy | NCT01957020 | Breast Cancer Stereotactic Di... Female Adult Patients | 30 Years - 80 Years | National Taiwan University Hospital | ||
| Treatment of Adult ALL With an MRD-directed Programme. | NCT00358072 | Acute Lymphobla... | Postremission c... | 15 Years - 65 Years | Northern Italy Leukemia Group | |
| LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma | NCT00412997 | Tumors Cutaneous T-Cel... | LBH589 | 20 Years - | Novartis | |
| Observational Study in Adults With Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated With Nilotinib | NCT01475110 | Chronic Myeloid... | Imatinib | 18 Years - | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients | NCT01951430 | Myelodysplastic... | Antibiotic and ... | 18 Years - | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin Lymphoma | NCT01290120 | Burkitt Lymphom... B-ALL | Chemotherapy-Ri... | 15 Years - | Northern Italy Leukemia Group | |
| A Remission Induction Therapy and Risk-oriented Postremission Strategy for Adult Acute Myelogenous Leukemia (AML) | NCT00495287 | Acute Myelogeno... | cytosine arabin... | 16 Years - 65 Years | Northern Italy Leukemia Group | |
| Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors | NCT01014429 | Advanced or Met... | NMS-1286937 | 18 Years - | Nerviano Medical Sciences | |
| Clofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) Adults | NCT01462253 | Acute Lymphobla... | Clofarabine, Cy... | 18 Years - 60 Years | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| A Risk-Oriented Therapeutic Strategy for Adult Acute Myelogenous Leukemia | NCT00400673 | Acute Myelogeno... | Two-step remiss... | 15 Years - 65 Years | Northern Italy Leukemia Group | |
| Anastomotic Leakage After Colon Cancer Surgery | NCT05643105 | Adult Patients Intestinal Cont... Colon Cancer | Any kind of col... | 18 Years - 99 Years | Hospital San Carlos, Madrid | |
| Allo CART-19 Protocol | NCT01551043 | Acute Lymphocyt... | CART-19 | 18 Years - | University of Pennsylvania | |
| Allo CART-19 Protocol | NCT01551043 | Acute Lymphocyt... | CART-19 | 18 Years - | University of Pennsylvania | |
| Treatment of Adult ALL With an MRD-directed Programme. | NCT00358072 | Acute Lymphobla... | Postremission c... | 15 Years - 65 Years | Northern Italy Leukemia Group | |
| Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic | NCT01703910 | Adenocarcinoma ... Adenocarcinoma ... Metastatic Dise... | Arm A chemother... arm B chemother... | 18 Years - 76 Years | Centro Nacional de Investigaciones Oncologicas CARLOS III | |
| Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients | NCT01951430 | Myelodysplastic... | Antibiotic and ... | 18 Years - | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| TAS-117 in Patients With Advanced Solid Tumors Harboring Germline PTEN Mutations | NCT04770246 | Advanced or Met... Advanced or Met... | TAS-117 TAS-117 TAS-117 TAS-117 | 12 Years - | Taiho Oncology, Inc. | |
| TAS-117 in Patients With Advanced Solid Tumors Harboring Germline PTEN Mutations | NCT04770246 | Advanced or Met... Advanced or Met... | TAS-117 TAS-117 TAS-117 TAS-117 | 12 Years - | Taiho Oncology, Inc. | |
| Study of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors | NCT01014429 | Advanced or Met... | NMS-1286937 | 18 Years - | Nerviano Medical Sciences |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
